{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:44:20Z","timestamp":1770511460362,"version":"3.49.0"},"reference-count":318,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","award":["320126"],"award-info":[{"award-number":["320126"]}],"id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01196","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T15:08:41Z","timestamp":1597331321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["COVID-19 Therapeutic Options Under Investigation"],"prefix":"10.3389","volume":"11","author":[{"given":"Malak","family":"Kaddoura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malak","family":"AlIbrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghina","family":"Hijazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Soudani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Audi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Alkalamouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salame","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Zaraket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01348-19","article-title":"Small-Molecule Antiviral \u03b2-d-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance","volume":"93","author":"Agostini","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/jac\/dkv018","article-title":"Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases","volume":"70","author":"Al-Bari","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijid.2013.12.003","article-title":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study","volume":"20","author":"Al-Tawfiq","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb. Pathog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.1365-2893.2001.00285.x","article-title":"In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C","volume":"8","author":"Andreone","year":"2001","journal-title":"J. Viral. Hepat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0005757","DOI":"10.1371\/journal.pntd.0005757","article-title":"Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus","volume":"11","author":"Angulo","year":"2017","journal-title":"PloS Negl. Trop. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome","volume":"197","author":"Arabi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijid.2020.06.099","article-title":"Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19","author":"Arshad","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12408650.v1","article-title":"Targeting SARS-CoV-2 Main Protease by Teicoplanin: A Mechanistic Insight by in Silico Studies","author":"Azam","year":"2020"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.bmcl.2014.06.018","article-title":"Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: Synthesis and antiviral studies","volume":"24","author":"Bakai-Bereczki","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.antiviral.2006.03.005","article-title":"Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics","volume":"72","author":"Balzarini","year":"2006","journal-title":"Antiviral Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.virol.2004.11.038","article-title":"Programmed ribosomal frameshifting in decoding the SARS-CoV genome","volume":"332","author":"Baranov","year":"2005","journal-title":"Virology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/095632020401500102","article-title":"Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and \u03b2-D-N4-Hydroxycytidine","volume":"15","author":"Barnard","year":"2004","journal-title":"Antivir. Chem. Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","article-title":"Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin","volume":"71","author":"Barnard","year":"2006","journal-title":"Antiviral Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"105944","DOI":"10.1016\/j.ijantimicag.2020.105944","article-title":"Teicoplanin: an alternative drug for the treatment of COVID-19","volume":"55","author":"Baron","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 \u2014 Preliminary Report","author":"Beigel","year":"2020","journal-title":"New Engl. J. Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B22","first-page":"698","article-title":"Thymosin alpha1. SciClone Pharmaceuticals","volume":"3","author":"Billich","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: An update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1016\/j.ajpath.2015.06.009","article-title":"Sphingosine-1-Phosphate Receptor Antagonism Enhances Proliferation and Migration of Engrafted Neural Progenitor Cells in a Model of Viral-Induced Demyelination","volume":"185","author":"Blanc","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1590\/0074-0276108052013010","article-title":"Chloroquine use improves dengue-related symptoms","volume":"108","author":"Borges","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.7164\/antibiotics.37.615","article-title":"Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin)","volume":"37","author":"Borghi","year":"1984","journal-title":"J. Antibiot."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4172\/1948-5964.1000173","article-title":"Azithromycin Inhibits the Replication of Zika Virus","volume":"10","author":"Bosseboeuf","year":"2018","journal-title":"J. Antivir. Antiretrovir."},{"key":"B29","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1056\/NEJMoa2016638","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","author":"Boulware","year":"2020","journal-title":"New Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e37244","DOI":"10.1371\/journal.pone.0037244","article-title":"An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro","volume":"7","author":"Burghgraeve","year":"2012","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"B32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.antiviral.2012.06.008","article-title":"Nuclear trafficking of proteins from RNA viruses: Potential target for antivirals","volume":"95","author":"Caly","year":"2012","journal-title":"Antiviral Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"B34","article-title":"Darunavir\/Cobicistat (Prezcobix)","volume-title":"Common Drug Review","year":"2015"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.010","article-title":"A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs","volume":"114","author":"Cao","year":"2015","journal-title":"Antiviral Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.vaccine.2011.12.014","article-title":"Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study","volume":"30","author":"Carraro","year":"2012","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1172\/jci138003","article-title":"The convalescent sera option for containing COVID-19","volume":"2","author":"Casadevall","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2249.2003.02331.x","article-title":"A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy","volume":"134","author":"Chadwick","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment With Lopinavir\/Ritonavir or Interferon-\u03b21b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"Chen","year":"2004","journal-title":"J. Clin. Virol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.17.20037432","article-title":"Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial","volume":"2020","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"B43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/22221751.2020.1725399","article-title":"RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B44","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41591-020-0888-2","article-title":"The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin","volume":"26","author":"Chorin","year":"2020","journal-title":"Nat. Med."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antiviral Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"B49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(03)13973-6","article-title":"Treatment of SARS with human interferons","volume":"362","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJMoa071255","article-title":"A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis","volume":"357","author":"Corneli","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B51","first-page":"133","article-title":"Binding of the glycopeptide antibiotic teicoplanin to D-alanyl-D-alanine-agarose: the effect of micellar aggregates","volume":"7","author":"Corti","year":"1985","journal-title":"J. Appl. Biochem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV","volume":"33","author":"De Clercq","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","article-title":"Molecular Interactions in the Assembly of Coronaviruses","volume":"64","author":"de Haan","year":"2005","journal-title":"Adv. Virus Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"201922083","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e2013136","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B58","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/v8120322","article-title":"Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against Corona Virus Disease 2019: A retrospective cohort study","volume":"81","author":"Deng","year":"2020","journal-title":"J. Infect"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.31219\/osf.io\/urxwh","article-title":"Suramin, Penciclovir and Anidulafungin bind nsp12, which governs the RNA-dependent-RNA polymerase activity of SARS-CoV-2, with higher interaction energy than Remdesivir, indicating potential in the treatment of Covid-19 infection","author":"Dey","year":"2020"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2020.1735227","article-title":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics","author":"Dhama","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.25781","article-title":"The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China","author":"Ding","year":"2020","journal-title":"J. Med. Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"B65","first-page":"135","article-title":"H1N1 Influenza A infection","volume":"13","author":"Dotis","year":"2009","journal-title":"Hippokratia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV \u2014 a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1128\/aac.36.12.2747","article-title":"Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus","volume":"36","author":"Earnshaw","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02395-16","article-title":"Characterization of \u03b2-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/ejhpharm-2018-001707","article-title":"Two regimens of dexamethasone versus prednisolone for acute exacerbations in asthmatic Egyptian children","volume":"27","author":"Elkharwili","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/srep01686","article-title":"Inhibition of novel \u03b2 coronavirus replication by a combination of interferon-\u03b12b and ribavirin","volume":"3","author":"Falzarano","year":"2013","journal-title":"Sci. Rep."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/282734","article-title":"Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6\/36 cells","volume":"2013","author":"Farias","year":"2013","journal-title":"Sci. World J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/vim.2014.0090","article-title":"Antiviral Activity of Chloroquine Against Dengue Virus Type 2 Replication in Aotus Monkeys","volume":"28","author":"Farias","year":"2015","journal-title":"Viral. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMp1600297","article-title":"Zika Virus in the Americas \u2014 Yet Another Arbovirus Threat","volume":"374","author":"Fauci","year":"2016","journal-title":"New Engl. J. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: An Overview of Their Replication and Pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.msard.2020.102180","article-title":"Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","volume":"42","author":"Foerch","year":"2020","journal-title":"Multiple Sclerosis Related Disord."},{"key":"B79","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/FPC.0000000000000270","article-title":"PharmGKB summary: macrolide antibiotic pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"B80","volume-title":"Highlights of Prescribing Information","year":"1986"},{"key":"B81","unstructured":"Chloroquine Phosphate2009"},{"key":"B82","unstructured":"Tablets Stromectol\u00ae (Ivermectin)2009"},{"key":"B83","unstructured":"Zithromax2010"},{"key":"B84","unstructured":"Plaquenil\u00ae Hydroxychloroquine Sulfate Tablets, USP2018"},{"key":"B85","unstructured":"FDARecommendations for Investigational COVID-19 Convalescent Plasma2020"},{"key":"B86","unstructured":"Kaletra (Lopinavir\/Ritonavir) NDA #21-226 & 21-251"},{"key":"B87","unstructured":"Food and Drug AdministrationC. for D. E FDAFDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome2019"},{"key":"B88","unstructured":"Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment2020"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: a new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.053","article-title":"Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study","author":"Freedberg","year":"2020","journal-title":"Gastroenterology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum\/Golgi Membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J. Virol."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00937","article-title":"A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic","volume":"11","author":"Funk","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"B94","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrobial. Agents"},{"key":"B95","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s13365-017-0571-7","article-title":"Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV","volume":"23","author":"Geffin","year":"2017","journal-title":"J. Neurovirol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"New Engl. J. Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/cid\/ciaa330","article-title":"Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study","volume":"71","author":"Giacomelli","year":"","journal-title":"Clin. Infect. Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur. Respir. J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1128\/JVI.00128-13","article-title":"The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies","volume":"87","author":"Gierer","year":"2013","journal-title":"J. Virol."},{"key":"B100","unstructured":"Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-192020"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19","author":"Goldman","year":"2020","journal-title":"New Engl. J. Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The Pharmacokinetics and Interactions of Ivermectin in Humans\u2014A Mini-review","volume":"10","author":"Gonz\u00e1lez Canga","year":"2008","journal-title":"AAPS J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep23138","article-title":"Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import","volume":"6","author":"G\u00f6tz","year":"2016","journal-title":"Sci. Rep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate Use of Remdesivir for Patients with Severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"New Engl. J. Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques","volume":"15","author":"Guedj","year":"2018","journal-title":"PloS Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/d41587-020-00013-z","article-title":"Drug researchers pursue new lines of attack against COVID-19","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/v10040184","article-title":"Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses","volume":"10","author":"Haviernik","year":"2018","journal-title":"Viruses"},{"key":"B110","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1128\/JVI.00631-14","article-title":"Identification of Diverse Alphacoronaviruses and Genomic Characterization of a Novel Severe Acute Respiratory Syndrome-Like Coronavirus from Bats in China","volume":"88","author":"He","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1099\/jgv.0.001283","article-title":"The broad-spectrum antiviral drug arbidol inhibits foot-and-mouth disease virus genome replication","volume":"100","author":"Herod","year":"2019","journal-title":"J. Gen. Virol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J."},{"key":"B114","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"781","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B115","unstructured":"HorbyP. LandrayM. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 \u2014 RECOVERY Trial2020"},{"key":"B116","volume-title":"No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY","author":"Horby","year":"2020"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-020-2404-8","article-title":"The effect of large-scale anti-contagion policies on the COVID-19 pandemic","author":"Hsiang","year":"2020","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3201\/eid0906.030264","article-title":"Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts","volume":"9","author":"Hsu","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J. Med. Virol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/s0140-6736(20)30252-x","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"B122","doi-asserted-by":"publisher","first-page":"13285","DOI":"10.1128\/JVI.79.21.13285-13297.2005","article-title":"A Major Determinant for Membrane Protein Interaction Localizes to the Carboxy-Terminal Domain of the Mouse Coronavirus Nucleocapsid Protein","volume":"79","author":"Hurst","year":"2005","journal-title":"J. Virol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2893.2005.00633.x","article-title":"The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial","volume":"12","author":"Iino","year":"2005","journal-title":"J. Viral. Hepat."},{"key":"B124","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1254\/fpj.122.527","article-title":"Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy","volume":"122","author":"Ikeda","year":"2003","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321852","article-title":"Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series","author":"Janowitz","year":"2020","journal-title":"Gut"},{"key":"B126","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ceb.2019.01.001","article-title":"Inhibitors of nuclear transport","volume":"58","author":"Jans","year":"2019","journal-title":"Curr. Opin. Cell Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.isci.2019.07.003","article-title":"The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus","volume":"19","author":"Jasenosky","year":"2019","journal-title":"iScience"},{"key":"B128","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.transproceed.2006.10.005","article-title":"Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation","volume":"39","author":"Ji","year":"2007","journal-title":"Transpl. Proc."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140200","article-title":"Early safety indicators of COVID-19 convalescent plasma in 5,000 patients","author":"Joyner","year":"2020","journal-title":"J. Clin. Invest"},{"key":"B130","doi-asserted-by":"publisher","first-page":"E008","DOI":"10.3760\/cma.j.cn311365-20200210-00050","article-title":"Efficacies of lopinavir\/ritonavir and abidol in the treatment of novel coronavirus pneumonia","volume":"38","author":"Jun","year":"2020","journal-title":"Chin. J. Infect. Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1165\/ajrcmb.22.6.3779","article-title":"Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema","volume":"22","author":"Kaner","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3904\/kjim.2020.157","article-title":"In vitro activity of lopinavir\/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses","volume":"35","author":"Kang","year":"2020","journal-title":"Korean J. Intern. Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100418","article-title":"Tocilizumab for treatment of patients with severe COVID\u201319: A retrospective cohort study","author":"Kewan","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B134","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B135","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B136","first-page":"9","article-title":"[Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures]","volume":"53","author":"Khamitov","year":"2008","journal-title":"Vopr. Virusol."},{"key":"B137","first-page":"9","article-title":"[A new antiviral drug Triazavirin: results of phase II clinical trial]","volume":"57","author":"Kiselev","year":"2012","journal-title":"Vopr. Virusol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3851\/IMP3243","article-title":"Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: A single centre experience","volume":"23","author":"Ko","year":"2018","journal-title":"Antiviral Ther."},{"key":"B139","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.antiviral.2007.10.011","article-title":"Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK","volume":"77","author":"Kono","year":"2008","journal-title":"Antiviral Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.antiviral.2007.08.005","article-title":"Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication","volume":"77","author":"Korba","year":"2008","journal-title":"Antiviral Res."},{"key":"B141","first-page":"1289","article-title":"Ribavirin in the treatment of SARS: A new trick for an old drug","volume":"168","author":"Koren","year":"2003","journal-title":"CMAJ"},{"key":"B142","first-page":"S462","article-title":"The combined treatment of interferon alpha-2a and thymosin alpha 1 for chronic hepatitis C: the 48 weeks end of treatment results","volume":"84","author":"Kullavanuaya","year":"2001","journal-title":"J. Med. Assoc. Thai"},{"key":"B143","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1128\/JVI.01213-13","article-title":"Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation","volume":"87","author":"La Frazia","year":"2013","journal-title":"J. Virol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","article-title":"The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application","volume":"172","author":"Lauer","year":"2020","journal-title":"Ann. Intern. Med"},{"key":"B145","first-page":"42","article-title":"[Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay]","volume":"47","author":"Leneva","year":"2002","journal-title":"Vopr. Virusol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine-Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"B147","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","article-title":"Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice","volume":"24","author":"Li","year":"2017","journal-title":"EBioMedicine"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00394-19","article-title":"Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses","volume":"63","author":"Li","year":"2019","journal-title":"Antimicrob. Agents Chemother"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2020.04.001","article-title":"Efficacy and Safety of Lopinavir\/Ritonavir or Arbidol in Adult Patients with Mild\/Moderate COVID-19: An Exploratory Randomized Controlled Trial","author":"Li","year":"2020","journal-title":"Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(04)15788-7","article-title":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors","volume":"363","author":"Liu","year":"2004","journal-title":"Lancet"},{"key":"B154","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discovery"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.20.20102236","article-title":"Convalescent plasma treatment of severe COVID-19: A matched control study","volume":"2020","author":"Liu","year":"2020","journal-title":"medRxiv"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa630","article-title":"Thymosin alpha 1 (T\u03b11) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells","author":"Liu","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau9242","article-title":"Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge","volume":"11","author":"Lo","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B159","first-page":"27","article-title":"Thymosins: structure, function and therapeutic applications","volume":"6","author":"Low","year":"1984","journal-title":"Thymus"},{"key":"B160","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"B161","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.antiviral.2013.10.004","article-title":"Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication","volume":"100","author":"Lundberg","year":"2013","journal-title":"Antiviral Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"B163","first-page":"55","article-title":"Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo","volume-title":"Antiviral Res","author":"Lv","year":"2018"},{"key":"B164","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola Virus Inhibitors for Drug Repurposing","volume":"1","author":"Madrid","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2020.06.001","article-title":"Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19","author":"Magagnoli","year":"2020","journal-title":"Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine"},{"key":"B167","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/jac\/dks217","article-title":"Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C","volume":"67","author":"Maieron","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1200\/JCO.2009.25.5208","article-title":"Large Randomized Study of Thymosin \u03b1 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma","volume":"28","author":"Maio","year":"2010","journal-title":"JCO"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e00804","DOI":"10.1002\/brb3.804","article-title":"Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort","volume":"7","author":"Manni","year":"2017","journal-title":"Brain Behav."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B171","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"PNAS"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa105","article-title":"Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/archinte.168.10.1034","article-title":"Use of Corticosteroids in Treating Infectious Diseases","volume":"168","author":"McGee","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/thx.2005.040204","article-title":"Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): Paradox or paradigm","volume":"61","author":"Medford","year":"2006","journal-title":"Thorax"},{"key":"B175","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"Correspondence COVID-19: consider cytokine storm syndromes and","volume":"6736","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B176","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1009","article-title":"Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial","author":"Mitj\u00e0","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"B178","first-page":"1","volume-title":"Ref. Module Biomed. Sci.","author":"Mondal","year":"2016"},{"key":"B179","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase Inhibitors for Influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"New Engl. J. Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"New Engl. J. Med."},{"key":"B182","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/B978-1-4557-4801-3.00030-8","article-title":"30 - Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), Lipopeptides (Daptomycin), and Lipoglycopeptides (Telavancin)","volume-title":"Mandell, Douglas, and Bennett\"s Principles and Practice of Infectious Diseases (Eighth Edition)","author":"Murray","year":"2015"},{"key":"B183","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1017\/dmp.2014.151","article-title":"Favipiravir: a new medication for the Ebola virus disease pandemic","volume":"9","author":"Nagata","year":"2015","journal-title":"Disaster Med. Public Health Prep."},{"key":"B184","article-title":"\u201cChloroquine\u201d in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012"},{"key":"B185","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","article-title":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","volume":"23","author":"Ni","year":"2019","journal-title":"Crit. Care"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(03)13413-7","article-title":"Lung pathology of fatal severe acute respiratory syndrome","volume":"361","author":"Nicholls","year":"2003","journal-title":"Lancet"},{"key":"B187","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/CMR.00045-07","article-title":"Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances","volume":"21","author":"Nichols","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.2147\/DDDT.S65255","article-title":"Changing the face of hepatitis C management - the design and development of sofosbuvir","volume":"9","author":"Noell","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jac\/dkr104","article-title":"Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics","volume":"66","author":"Obeid","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B190","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1743-422X-3-39","article-title":"In vitro inhibition of human influenza A virus replication by chloroquine","volume":"3","author":"Ooi","year":"2006","journal-title":"Virol. J."},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104597","article-title":"The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection","volume":"171","author":"Painter","year":"2019","journal-title":"Antiviral Res."},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000620","article-title":"Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study","volume":"115","author":"Pan","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"B193","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-7020-6285-8.00145-3","article-title":"145 - Glycopeptides","volume-title":"Infectious Diseases","author":"Parente","year":"2017"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.31.276","article-title":"Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I","author":"Parenti","year":"1978"},{"key":"B195","first-page":"115","article-title":"Introducing New Antimalarial Analogues of Chloroquine and Amodiaquine: A Narrative Review","volume":"42","author":"Parhizgar","year":"2017","journal-title":"Iran J. Med. Sci."},{"key":"B196","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jama.2012.6936","article-title":"Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial","volume":"308","author":"Paton","year":"2012","journal-title":"JAMA"},{"key":"B197","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1128\/JVI.02077-15","article-title":"The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses","volume":"90","author":"P\u00e9cheur","year":"2016","journal-title":"J. Virol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0140-6736(20)30788-1","article-title":"Developing antibody tests for SARS-CoV-2","volume":"395","author":"Petherick","year":"2020","journal-title":"Lancet"},{"key":"B199","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1212\/WNL.0000000000001659","article-title":"Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis","volume":"84","author":"Pfender","year":"2015","journal-title":"Neurology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104211","article-title":"Novel coronavirus: From discovery to clinical diagnostics","volume":"79","author":"Phan","year":"2020","journal-title":"Infection Genet. Evol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"e1008081","DOI":"10.1371\/journal.ppat.1008081","article-title":"Fingolimod retains cytolytic T cells and limits T follicular helper cell infection in lymphoid sites of SIV persistence","volume":"15","author":"Pino","year":"2019","journal-title":"PloS Pathog."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa030634","article-title":"Identification of Severe Acute Respiratory Syndrome in Canada","volume":"348","author":"Poutanen","year":"2003","journal-title":"New Engl. J. Med."},{"key":"B203","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.antiviral.2006.04.008","article-title":"Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry","volume":"71","author":"Preobrazhenskaya","year":"2006","journal-title":"Antiviral Res."},{"key":"B204","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1128\/AAC.01598-05","article-title":"Inhibition of Human Coronavirus NL63 Infection at Early Stages of the Replication Cycle","volume":"50","author":"Pyrc","year":"2006","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4065\/mcp.2011.0309","article-title":"Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus","volume":"86","author":"Razonable","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16387","article-title":"Cutaneous manifestations in COVID-19: a first perspective","volume":"34","author":"Recalcati","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.cmi.2018.01.030","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)","volume":"24","author":"Redelman-Sidi","year":"2018","journal-title":"Clin. Microbiol. Infection"},{"key":"B208","unstructured":"Regeneron Pharmaceuticals IncRegeneron and Sanofi Provide Update on U.S. Phase 2\/3 Adaptive-Designed Trial of Kevzara\u00ae (sarilumab) in Hospitalized COVID-19 Patients2020"},{"key":"B209","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.3390\/v7122934","article-title":"Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication","volume":"7","author":"Reynard","year":"2015","journal-title":"Viruses"},{"key":"B210","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2174\/1381612043383791","article-title":"Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity","volume":"10","author":"Romanelli","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3201\/eid2409.180233","article-title":"Use of Favipiravir to Treat Lassa Virus Infection in Macaques - Volume 24, Number 9\u2014September 2018 - Emerging Infectious","volume":"24","author":"Rosenke","year":"2018","journal-title":"Dis. J. - CDC"},{"key":"B212","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: A first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res."},{"key":"B213","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"Rossignol","year":"2016","journal-title":"J. Infect. Public Health"},{"key":"B214","doi-asserted-by":"publisher","first-page":"11507","DOI":"10.1128\/JVI.79.17.11507-11512.2005","article-title":"Intracellular Localization of the Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein: Absence of Nucleolar Accumulation during Infection and after Expression as a Recombinant Protein in Vero Cells","volume":"79","author":"Rowland","year":"2005","journal-title":"J. Virol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"B216","unstructured":"RudolphA. R. TuthillC. W. Treatment or prevention of respiratory viral infections with alpha thymosin peptides2010"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3332\/ecancer.2020.1022","article-title":"Associations between immune-suppressive and stimulating drugs and novel COVID-19\u2014a systematic review of current evidence","volume":"14","author":"Russell","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"B218","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.ajpath.2020.05.014","article-title":"Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma","volume":"190","author":"Salazar","year":"2020","journal-title":"Am. J. Pathol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1128\/AAC.00649-13","article-title":"Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B221","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"B222","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1183\/09031936.00102014","article-title":"Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells","volume":"45","author":"Sch\u00f6gler","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B224","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"B225","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","author":"Sheahan","year":"2020","journal-title":"Sci. Trans. Med"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-11-10","article-title":"Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model","volume":"11","author":"Shi","year":"2014","journal-title":"Virol. J."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15467-6","article-title":"Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis","volume":"7","author":"Shiryaev","year":"2017","journal-title":"Sci. Rep."},{"key":"B228","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2147\/IMCRJ.S220499","article-title":"Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy","volume":"12","author":"Shrestha","year":"2019","journal-title":"Int. Med. Case Rep. J."},{"key":"B229","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1080\/07391102.2017.1367329","article-title":"Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure","volume":"36","author":"Shvetsov","year":"2018","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"B230","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"B231","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A Review of Coronavirus Disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J. Pediatr."},{"key":"B232","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1128\/JVI.01052-08","article-title":"The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles","volume":"82","author":"Siu","year":"2008","journal-title":"J. Virol."},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19","author":"Skipper","year":"2020","journal-title":"Ann. Internal Med"},{"key":"B234","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s12325-011-0072-7","article-title":"Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience","volume":"28","author":"Smith","year":"2011","journal-title":"Adv. Ther."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: Systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PloS Med."},{"key":"B236","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"New Engl. J. Med."},{"key":"B237","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1128\/AAC.47.1.244-254.2003","article-title":"Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture","volume":"47","author":"Stuyver","year":"2003","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B238","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J. Virol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/thx.2003.014076","article-title":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak","volume":"59","author":"Sung","year":"2004","journal-title":"Thorax"},{"key":"B241","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1128\/AAC.00341-09","article-title":"Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis","volume":"53","author":"Svetitsky","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","author":"Tai","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3201\/eid1004.030458","article-title":"Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs","volume":"10","author":"Tan","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"B244","doi-asserted-by":"publisher","first-page":"e0206416","DOI":"10.1371\/journal.pone.0206416","article-title":"Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration","volume":"13","author":"Tani","year":"2018","journal-title":"PloS One"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/bjd.19011","article-title":"Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department","volume":"182","author":"Tao","year":"","journal-title":"Br. J. Dermatol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear localization of dengue virus (DENV) 1\u20134 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin","volume":"99","author":"Tay","year":"2013","journal-title":"Antiviral Res."},{"key":"B247","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/v11040326","article-title":"Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir","volume":"11","author":"Tchesnokov","year":"2019","journal-title":"Viruses"},{"key":"B248","first-page":"218","article-title":"Mechanism of Action of Ribavirin in the Treatment of Chronic Hepatitis C","volume":"3","author":"Te","year":"2007","journal-title":"Gastroenterol. Hepatol. (N. Y.)"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19 \u2014 Preliminary Report","year":"2020","journal-title":"New Engl. J. Med"},{"key":"B250","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virusres.2005.05.007","article-title":"Nuclear\/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus","volume":"114","author":"Timani","year":"2005","journal-title":"Virus Res."},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax5866","article-title":"Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia","volume":"11","author":"Toots","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B252","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41429-019-0204-x","article-title":"Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process","volume":"72","author":"Tran","year":"2019","journal-title":"J. Antibiot."},{"key":"B253","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PloS Negl. Trop. Dis."},{"key":"B254","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/20477724.2016.1181294","article-title":"Human coronavirus and severe acute respiratory infection in Southern Brazil","volume":"110","author":"Trombetta","year":"2016","journal-title":"Pathog. Glob. Health"},{"key":"B255","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/aid.1990.6.481","article-title":"Inhibition of Human Immunodeficiency Virus Infectivity by Chloroquine","volume":"6","author":"Tsai","year":"1990","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01965-17","article-title":"\u03b2-d-N4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome","volume":"92","author":"Urakova","year":"2018","journal-title":"J. Virol."},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01057","article-title":"The Role of Interleukin 6 During Viral Infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"key":"B258","doi-asserted-by":"publisher","first-page":"CD000181","DOI":"10.1002\/14651858.CD000181.pub2","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children","author":"Ventre","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"B259","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1750-2659.2007.00027.x","article-title":"Chloroquine is effective against influenza A virus in vitro but not in vivo","volume":"1","author":"Vigerust","year":"2007","journal-title":"Influenza Other Respir. Viruses"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Viveiros Rosa","year":"2020","journal-title":"Rev. Panam. Salud Publica"},{"key":"B262","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"key":"B263","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"key":"B264","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.bcp.2011.01.001","article-title":"FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells","volume":"81","author":"Wang","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/jir.2014.0038","article-title":"Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery","volume":"35","author":"Wang","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.5772\/64403","article-title":"Influenza Inactive Virus Vaccine with the Fusion Peptide (rT\u03b11- BP5) Enhances Protection Against Influenza Through Humoral and Cell-Mediated Immunity","author":"Wang","year":"2016","journal-title":"Steps Forwards Diagnosing Controlling Influenza"},{"key":"B267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2015.11.003","article-title":"Teicoplanin inhibits Ebola pseudovirus infection in cell culture","volume":"125","author":"Wang","year":"2016","journal-title":"Antiviral Res."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus\u2013Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105948","article-title":"Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence","volume":"55","author":"Wang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B270","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus, (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-03808-5","article-title":"Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-\u03baB pathway in collagen-induced arthritis rats","author":"Wang","year":"2020","journal-title":"Mol. Cell. Biochem"},{"key":"B272","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-020-0169-8","article-title":"The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro","volume":"6","author":"Wang","year":"2020","journal-title":"Cell Discovery"},{"key":"B273","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"B274","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang","year":"2020","journal-title":"BioSci. Trends"},{"key":"B275","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China","volume":"71","author":"Wang","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"B276","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"B277","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/14787210.2.1.43","article-title":"Nitazoxanide: a new broad spectrum antiparasitic agent","volume":"2","author":"White","year":"2004","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"B279","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.07.939207","article-title":"Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019","volume":"2020","author":"Wong","year":"2020","journal-title":"bioRxiv"},{"key":"B281","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/JVI.06540-11","article-title":"Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus","volume":"86","author":"Woo","year":"2012","journal-title":"J. Virol."},{"key":"B282","first-page":"225","article-title":"Interleukin 6 inhibition: RA and beyond","volume":"69","author":"Woodrick","year":"2011","journal-title":"Bull. NYU Hosp. Joint Dis."},{"key":"B283","unstructured":"World Health Organization Pneumonia of unknown cause \u2013 China"},{"key":"B284","unstructured":"Coronavirus disease 2019 (COVID-19) Situation Report \u2013 462020"},{"key":"B285","unstructured":"Coronavirus Disease (COVID-19) - events as they happen2020"},{"key":"B286","doi-asserted-by":"crossref","unstructured":"Coronavirus Disease (COVID-19) Situation Reports2020","DOI":"10.17265\/1537-1506\/2020.03.002"},{"key":"B287","unstructured":"WHO discontinues hydroxychloroquine and lopinavir\/ritonavir treatment arms for COVID-192020"},{"key":"B288","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B."},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00553","article-title":"Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses","volume":"6","author":"Wulan","year":"2015","journal-title":"Front. Microbiol."},{"key":"B290","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"PNAS"},{"key":"B291","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/infdis\/jiv586","article-title":"Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis","volume":"213","author":"Yamada","year":"2016","journal-title":"J. Infect. Dis."},{"key":"B292","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1128\/AAC.01043-16","article-title":"Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay","volume":"60","author":"Yamamoto","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B293","article-title":"Efficacy and Safety of Ivermectin against Dengue Infection: A Phase III, Randomized, Double-blind, Placebo-controlled Trial","author":"Yamasmith","year":"2018"},{"key":"B294","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pupt.2015.07.001","article-title":"The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells","volume":"33","author":"Yamaya","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B295","doi-asserted-by":"publisher","first-page":"2000799","DOI":"10.1183\/13993003.00799-2020","article-title":"Factors associated with prolonged viral shedding and impact of Lopinavir\/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection","volume":"56","author":"Yan","year":"2020","journal-title":"Eur. Respir. J"},{"key":"B296","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN","volume":"78","author":"Yang","year":"2004","journal-title":"J. Virol."},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00249","article-title":"Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals","volume":"8","author":"Yang","year":"2020","journal-title":"Front. Public Health"},{"key":"B298","doi-asserted-by":"publisher","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antiviral Res."},{"key":"B299","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B300","article-title":"Corticosteroid Adverse Effects","volume-title":"StatPearls","author":"Yasir","year":"2020"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-18","article-title":"Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses","volume":"62","author":"Yoon","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B302","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"B303","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104547","article-title":"Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus","volume":"169","author":"Zhang","year":"2019","journal-title":"Antiviral Res."},{"key":"B305","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B306","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cub.2020.03.022","article-title":"Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak","volume":"30","author":"Zhang","year":"2020","journal-title":"Curr. Biol."},{"key":"B307","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv."},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.05.935387","article-title":"Teicoplanin potently blocks the cell entry of 2019-nCoV","volume":"2020","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"key":"B309","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11596-020-2203-3","article-title":"Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission\u2014A Preliminary Report of a Retrospective Cohort Study","volume":"40","author":"Zhang","year":"2020","journal-title":"Curr. Med. Sci."},{"key":"B310","doi-asserted-by":"publisher","first-page":"480","DOI":"10.12074\/202002.00065","article-title":"Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission","volume":"40","author":"Zhang","year":"2020","journal-title":"Curr. Med. Sci."},{"key":"B311","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/s0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"B312","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3851\/IMP2292","article-title":"Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant HBV clinical isolates","volume":"17","author":"Zhou","year":"2012","journal-title":"Antivir. Ther. (Lond.)"},{"key":"B313","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antiviral Res."},{"key":"B314","doi-asserted-by":"publisher","first-page":"9218","DOI":"10.1074\/jbc.M116.716100","article-title":"Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome\/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B315","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.09.20076646","article-title":"Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment: a retrospective cohort study","volume":"2020","author":"Zhou","year":"2020","journal-title":"medRxiv"},{"key":"B317","doi-asserted-by":"publisher","first-page":"13407","DOI":"10.1128\/JVI.00903-12","article-title":"Japanese Encephalitis Virus Enters Rat Neuroblastoma Cells via a pH-Dependent, Dynamin and Caveola-Mediated Endocytosis Pathway","volume":"86","author":"Zhu","year":"2012","journal-title":"J. Virol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01196\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T09:41:49Z","timestamp":1616924509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01196\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":318,"alternative-id":["10.3389\/fphar.2020.01196"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01196","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"article-number":"1196"}}